Title 16, TITLE 16. HEALTH

Sec. 0.3. (a) As used in this chapter, "de-identified maximum negotiated charge" means the highest charge that an ambulatory outpatient surgical center has negotiated with any third party payer for an item or service. (b) As used in this chapter, "de-identified minimum negotiated…

As added by P.L.93-2020, SEC.3. Repealed by P.L.151-2021, SEC.10 and P.L.198-2021, SEC.13.

Sec. 1. (a) Not later than December 31, 2021, an ambulatory outpatient surgical center shall post on the Internet web site of the ambulatory outpatient surgical center pricing and other information specified in this chapter for the following: (1) For as many of the seventy (70) s…

Sec. 2. (a) The information displayed on the Internet web site must be in an easy to read, understandable format, and include the standard charges as described in section 1 of this chapter for each service. (b) An ambulatory outpatient surgical center shall update the information…

Sec. 1. As used in this chapter, "waste blood specimen" means a blood sample or a solid, liquid, or semiliquid blood product that: (1) has served the intended purpose under section 4 of this chapter; or (2) has served the natural, biological, medical, or intended purpose and has …

specimen confidentiality Sec. 10. (a) The state department shall develop the following: (1) A registry for tracking and follow-up of all newborns and individuals for screening. (2) A centralized program that provides follow-up, diagnosis, management, and family counseling and sup…

Sec. 11. (a) The newborn screening fund is established for the purpose of carrying out this chapter. The state department shall administer the fund. (b) The expenses of the newborn screening program shall be paid from money in the fund. (c) Money in the fund at the end of a state…

Sec. 2. (a) Subject to subsection (d), every infant shall be given examinations at the earliest feasible time for the detection of the following disorders: (1) Phenylketonuria. (2) Hypothyroidism. (3) Hemoglobinopathies, including sickle cell anemia. (4) Galactosemia. (5) Maple S…

Sec. 3. The state department shall conduct an intensive educational program among physicians, hospitals, public health nurses, and the public concerning the disorders listed in section 2 of this chapter. The educational program must include information about: (1) the nature of th…

Sec. 4. After consultation with medical authorities, the state department shall require appropriate tests to be used in the detection of disorders listed in section 2 of this chapter. [Pre-1993 Recodification Citation: 16-8-6-3.] As added by P.L.2-1993, SEC.24.

Sec. 5. The state department and all local boards of health shall encourage and promote the development of plans and procedures for the detection of the disorders listed in section 2 of this chapter in all local health jurisdictions of Indiana. [Pre-1993 Recodification Citation: …

Sec. 6. (a) The state department shall provide forms on which the results of tests performed on each child for the disorders listed in section 2 of this chapter shall be reported to the state department by physicians and hospitals. (b) The state department shall ascertain at leas…

Sec. 7. (a) The state department shall designate at least one (1) laboratory for testing for disorders listed in section 2(a) of this chapter. (b) The designated laboratories shall perform tests on all infants for the detection of disorders under section 2(a) of this chapter. (c)…

Sec. 8. (a) Each hospital and physician shall: (1) subject to subsection (b), take or cause to be taken a blood sample from every infant born under the hospital's and physician's care; and (2) transport or cause to be transported each blood sample described in subdivision (1) to …

Sec. 9. The state department shall adopt rules under IC 4-22-2 to carry out this chapter, including rules to ensure the following: (1) Proper and timely sample collection and transportation under section 8 of this chapter. (2) Quality testing procedures at the laboratories design…

Sec. 1. Notwithstanding any rule or regulation adopted by the federal Food and Drug Administration concerning sodium saccharin, N.F., the chemical substance sodium saccharin, N.F. may be manufactured, distributed, sold, and used within Indiana. [Pre-1993 Recodification Citation: …

Sec. 2. (a) The Indiana board of pharmacy and the state department may not prohibit the manufacture, distribution, sale, or use of sodium saccharin, N.F. within Indiana, either as a component of any other substance produced within Indiana or as a separate product. (b) The state d…

Sec. 3. A person who is engaged in the manufacture, sale, distribution, or use of sodium saccharin, N.F. may not be prohibited from the manufacture, sale, distribution, or use of sodium saccharin, N.F. within Indiana. [Pre-1993 Recodification Citation: 16-8-9-3.] As added by P.L.…

Sec. 1. As used in this chapter, "council" refers to the rare disease advisory council established by section 2 of this chapter. As added by P.L.129-2023, SEC.2.

Sec. 10. Eight (8) members of the council constitute a quorum. The affirmative vote of a majority of the quorum is required for the council to take any action. As added by P.L.129-2023, SEC.2.

Sec. 11. (a) Each member of the council who is not a state employee is entitled to receive both of the following: (1) The minimum salary per diem provided by IC 4-10-11-2.1(b). (2) Reimbursement for travel expenses and other expenses actually incurred in connection with the membe…

Sec. 12. The state department shall provide administrative assistance to and pay the administrative expenses of the council. As added by P.L.129-2023, SEC.2.

Sec. 13. (a) Beginning January 1, 2024, the council shall submit an annual report to the governor and the legislative council not later than June 15. The report submitted to the legislative council must be in an electronic format under IC 5-14-6. (b) The report required in subsec…

Sec. 2. The rare disease advisory council is established. As added by P.L.129-2023, SEC.2.

Sec. 3. The duties of the council include the following: (1) Conduct public meetings to survey the needs of patients in Indiana with rare diseases and their caregivers and providers. (2) Provide testimony, comments, and recommendations concerning legislation and rules that impact…

Sec. 4. (a) Beginning July 1, 2026, a chairperson shall be elected by the council members at the first meeting after July 1 every even-numbered year. If a vacancy occurs in the position of a member who is the chairperson, the council shall elect a member to serve the remainder of…

Sec. 5. (a) The following individuals serve as ex officio voting members of the council: (1) The director of the office of Medicaid policy and planning or the director's designee. (2) The commissioner of the department of insurance or the commissioner's designee. (3) The chief op…

Sec. 6. (a) The term of a member appointed to the council is four (4) years. (b) Terms for appointed members begin on July 1 and end on June 30 of an odd-numbered year. (c) An appointed member may not serve more than one (1) complete term. (d) Notwithstanding subsection (a), the …

Sec. 7. A member of the council may be removed by the governor for cause. As added by P.L.129-2023, SEC.2.

Sec. 8. If a vacancy occurs on the council, the governor shall appoint a qualified individual to serve the remainder of the term within sixty (60) days of receiving notice of the vacancy. As added by P.L.129-2023, SEC.2.

Sec. 9. (a) The council must conduct a meeting before October 1, 2023. The initial meeting must be held on a date selected by a majority of the members of the council. The chairperson shall call all subsequent meetings. (b) Between September 1, 2023, and September 1, 2024, the co…